Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Lancet. Oncology|June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trialWilliam D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.Cancers|March 29, 2023
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and DesignBradford S Hoppe, Ivy A Petersen, Benjamin K Wilke, et al.The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled TrialMrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.Pageof 8